Delfi Diagnostics to Showcase Breadth of its Next-Generation Liquid Biopsy Platform at the American Association for Cancer Research Annual Meeting
/PRNewswire/ -- Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection...